Skip to main content

Advertisement

Table 1 Patient and tumour characteristics

From: Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer

  Number Percent
Tumour size
 ≤50 mm 613 80.1
 >50 mm 152 19.9
 Total 765 100
Node status
 Negative 388 50.7
 Positive 377 49.3
 Total 765 100
Grade
 1 22 2.9
 2 245 32
 3 328 42.9
 Missing 170 22.2
 Total 765 100
Taxane sequence
 Taxane first 387 50.6
 Taxane second 378 49.4
 Total 765 100
pCR
 No pCR 633 82.7
 pCR 122 15.9
 Missing 10 1.3
 Total 765 100
ER, HER2 status
 ER–, HER2– 152 19.9
 ER–, HER2+ 64 8.4
 ER+, HER2– 342 44.7
 ER+, HER2+ 116 15.2
 Missing 91 11.9
 Total 765 100
Diagnostic biopsies
 Missing 142 18.6
 Analysed 623 81.4
 Total 765 100
Surgical samples
 Missing 66 8.6
 Analysed 699 91.4
 Total 765 100
  1. pCR pathological complete response, ER oestrogen receptor, HER2 human epidermal growth factor receptor 2